Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?

[1]  B. Bogerts,et al.  Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[2]  M. Holtze,et al.  Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. , 2012, Schizophrenia bulletin.

[3]  B. Bogerts,et al.  Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission? , 2012 .

[4]  Peter Boesiger,et al.  Reduced negative BOLD responses in the default-mode network and increased self-focus in depression , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[5]  Michael Kometer,et al.  The neurobiology of psychedelic drugs: implications for the treatment of mood disorders , 2010, Nature Reviews Neuroscience.

[6]  D. Luckenbaugh,et al.  A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression. , 2010, Archives of general psychiatry.

[7]  P. Barone,et al.  Peripheral and cerebral metabolic abnormalities of the tryptophan–kynurenine pathway in a murine model of major depression , 2010, Behavioural Brain Research.

[8]  Huiguang He,et al.  Glutamatergic and Resting-State Functional Connectivity Correlates of Severity in Major Depression – The Role of Pregenual Anterior Cingulate Cortex and Anterior Insula , 2010, Front. Syst. Neurosci..

[9]  Tom Holroyd,et al.  Anterior Cingulate Desynchronization and Functional Connectivity with the Amygdala During a Working Memory Task Predict Rapid Antidepressant Response to Ketamine , 2010, Neuropsychopharmacology.

[10]  Y. Levkovitz,et al.  A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia. , 2010, The Journal of clinical psychiatry.

[11]  R. Drexhage,et al.  The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder , 2010, Expert review of neurotherapeutics.

[12]  R. Dantzer,et al.  CSF Concentrations of Brain Tryptophan and Kynurenines during Immune Stimulation with IFN-alpha: Relationship to CNS Immune Responses and Depression , 2009, Molecular Psychiatry.

[13]  D. Charney,et al.  Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression , 2009, Biological Psychiatry.

[14]  A. Schleicher,et al.  Receptor architecture of human cingulate cortex: Evaluation of the four‐region neurobiological model , 2009, Human brain mapping.

[15]  Peter Boesiger,et al.  The relationship between aberrant neuronal activation in the pregenual anterior cingulate, altered glutamatergic metabolism, and anhedonia in major depression. , 2009, Archives of general psychiatry.

[16]  Charles L. Raison,et al.  Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.

[17]  T. Connor,et al.  Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: A role for IFN-γ? , 2008, Neuroscience Letters.

[18]  A. Patkar,et al.  Does minocycline have antidepressant effect? , 2008, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  Carlos A. Zarate,et al.  Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders , 2008, Nature Reviews Drug Discovery.

[20]  W. Nolen,et al.  A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. , 2008, Archives of general psychiatry.

[21]  M. Molina-hernandez,et al.  Antidepressant-like actions of minocycline combined with several glutamate antagonists , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[22]  K. Ressler,et al.  Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic , 2007, Nature Neuroscience.

[23]  H. Steinbusch,et al.  Kynurenine pathway in major depression: evidence of impaired neuroprotection. , 2007, Journal of affective disorders.

[24]  S. Akhondzadeh,et al.  Celecoxib as adjunctive therapy in schizophrenia: A double-blind, randomized and placebo-controlled trial , 2007, Schizophrenia Research.

[25]  H. Yasuda,et al.  Possible antipsychotic effects of minocycline in patients with schizophrenia , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[26]  Paul J Carlson,et al.  A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. , 2006, Archives of general psychiatry.

[27]  B. Bogerts,et al.  Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization , 2006, Acta Neuropathologica.

[28]  K. Blennow,et al.  Elevated levels of kynurenic acid in the cerebrospinal fluid of male patients with schizophrenia , 2005, Schizophrenia Research.

[29]  P. Renshaw,et al.  Reduced Anterior Cingulate Glutamate in Pediatric Major Depression: A Magnetic Resonance Spectroscopy Study , 2005, Biological Psychiatry.

[30]  H. Steinbusch,et al.  Th1, Th2, and Th3 cytokine alterations in major depression. , 2005, Journal of affective disorders.

[31]  V. Arolt,et al.  Different activation patterns of proinflammatory cytokines in melancholic and non-melancholic major depression are associated with HPA axis activity. , 2005, Journal of affective disorders.

[32]  J. Lauriello,et al.  Effects of ketamine on anterior cingulate glutamate metabolism in healthy humans: a 4-T proton MRS study. , 2005, The American journal of psychiatry.

[33]  Y. Kim,et al.  Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. , 2003, Medical hypotheses.

[34]  K. Blennow,et al.  Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia , 2001, Neuroscience Letters.

[35]  E. Zorrilla,et al.  The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review , 2001, Brain, Behavior, and Immunity.

[36]  B. Brew,et al.  Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection , 2001, Journal of neurochemistry.

[37]  B. Brew,et al.  Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis , 2000, Redox report : communications in free radical research.

[38]  Bernadette Lipinski,et al.  Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study , 2000, Biological Psychiatry.

[39]  V. Arolt,et al.  Major depressive disorder is associated with elevated monocyte counts , 1996, Acta psychiatrica Scandinavica.

[40]  B. Hu,et al.  Interleukin-1 enhances indoleamine 2,3-dioxygenase activity by increasing specific mRNA expression in human mononuclear phagocytes. , 1995, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[41]  P. Cosyns,et al.  Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. , 1992, Journal of psychiatric research.

[42]  M. Rey,et al.  Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. , 1989, International clinical psychopharmacology.

[43]  T. Smith,et al.  Low natural killer cytotoxicity in major depression. , 1987, Life sciences.

[44]  P. Perry,et al.  Sedative/Hypnotic Dependence: Patient Stabilization, Tolerance Testing, and Withdrawal , 1986, Drug intelligence & clinical pharmacy.

[45]  S. Hsu,et al.  Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry. , 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[46]  Denis Dooley,et al.  Atlas of the Human Brain. , 1971 .

[47]  Norbert Müller,et al.  COX-2 inhibitors as antidepressants and antipsychotics: clinical evidence. , 2010, Current opinion in investigational drugs.

[48]  B. Brew,et al.  Involvement of quinolinic acid in aids dementia complex , 2009, Neurotoxicity Research.

[49]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[50]  B. Bogerts,et al.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. , 2008, Journal of psychiatric research.

[51]  B. Brew,et al.  Expression of indoleamine 2,3‐dioxygenase and production of quinolinic acid by human microglia, astrocytes, and neurons , 2005, Glia.

[52]  E. Bosmans,et al.  Absolute number and percentage of circulating natural killer, non-MHC-restricted T cytotoxic, and phagocytic cells in unipolar depression. , 1994, Neuropsychobiology.

[53]  J. D. House,et al.  Depression, hypothalamic-pituitary-adrenocortical activity, and lymphocyte function. , 1985, Psychopharmacology bulletin.